Phathom Pharmaceuticals, Inc. has secured 10 years of FDA exclusivity for Voquezna in GERD, boosting its stock. Click here to ...

TOKYO -- U.S. proxy advisory firm Institutional Shareholder Services (ISS) is recommending shareholders vote against the ...

Japanese borrowers have already sold more corporate bonds than they have for any June in four years, and the month isn’t even ...

No-moat Takeda Pharmaceutical is Japan’s leading pharmaceutical company by revenue. While the firm historically focused on the Japan market, management has undertaken an ambitious overhaul to ...

The growing prevalence of uterine fibroids, especially among women of reproductive age, is fueling the demand for treatment devices. This surge is fu ...

Takeda Pharmaceutical Company Limited (NYSE: TAK )’s ADCETRIS® (brentuximab vedotin) in combination with ECADD was authorized ...

Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers ...

Takeda Pharmaceutical (NYSE:TAK – Get Free Report) last released its quarterly earnings results on Thursday, May 8th.The company reported $0.16 earnings per share (EPS) for the quarter, missing ...

any question and answer session and any written or oral material discussed or distributed by Takeda Pharmaceutical Company Limited (“Takeda”) regarding this release. This press release ...

Researchers have developed a novel method for simultaneously recording action potentials (APs)—temporary changes in ...